AbCellera Biologics (ABCL) PT Lowered to $38 at Berenberg
Tweet
Share
E-mailGet Alerts ABCL Hot Sheet
Price: $11.36 +0.71%
Rating Summary:
12 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 32
Rating Summary:
12 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 32
Join SI Premium – FREE
Berenberg analyst Gaurav Goparaju lowered the price target on AbCellera Biologics (NASDAQ: ABCL) to $38.00 (from $43.00) while maintaining a Buy rating.
You May Also Be Interested In
- Reliance Industries (RELIANCE:IN) PT Lowered to INR1,625 at JPMorgan
- National Health Investors (NHI) PT Lowered to $80 at Truist Securities
- JPMorgan Downgrades ZTO Express (ZTO) to Overweight
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
